Global Advanced Therapy Medicinal Products (ATMPs) Market Executive Summary
Advanced Therapy Medicinal Products (ATMPs) are cutting-edge therapies that include cell therapy, gene therapy, and tissue-engineered products. Cellular immunotherapies and autologous and allogeneic cells, including mature and embryonic stem cells, are included in the category of cell therapy products. Human gene therapy, on the other hand, is a class of products that introduces genomic material into a person's DNA to replace missing or defective genetic material, thereby curing a disease or abnormal medical condition.
Market Size and Key Findings
The Global Advanced Therapy Medicinal Products (ATMPs) Market size is at around US $ xx Bn in 2021 and is projected to reach US $ xx Bn in 2030, exhibiting a CAGR of xx% during the forecast period.
Global Advanced Therapy Medicinal Products (ATMPs) Market Size (In USD Bn)
(2021-2030F)
Market Dynamics
Market Growth Drivers Analysis
The ATMPs (Advanced Therapy Medicinal Products) can potentially treat the underlying cause of diseases rather than just treat the symptoms. As a result, ATMPs aid in providing transformative benefits that conventional therapies do not. Over the course of the forecast period, these factors are anticipated to drive the market.
Market Restraints
The market is growing at a profitable rate despite the expensive products. The various health advantages offered by new classes of therapies are credited with the growth rate.
Aiming to overcome obstacles and increase the use of medicinal products for advanced therapy, market participants are registering the clinical benefits and efficacy of their products.
Competitive Landscape
Key Players
The prominent players operating in this market include Novartis AG (Switzerland), Gilead Sciences Inc. (US), JCR Pharmaceuticals Co., Ltd. (Japan), Bristol-Myers Squibb Company (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bluebird Bio Inc. (US), UniQure N.V. (Netherlands), Kolon TissueGene, Inc. (South Korea), Vericel Corporation (US) and PHARMICELL Co., Ltd. (South Korea)
TABLE OF CONTENT
1. Report Description of the Global Advanced Therapy Medicinal Products (ATMPs) Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. Global Advanced Therapy Medicinal Products (ATMPs) Market Executive Summary
2.1 Global Advanced Therapy Medicinal Products (ATMPs) Market – Industry Snapshot & key buying criteria, 2021-2030
2.2 Market Size, Growth Prospects, and Key findings
3. Market Dynamics of Global Advanced Therapy Medicinal Products (ATMPs) Market
3.1 Market Growth Drivers Analysis
3.2 Market Restrains Analysis
4. Global Advanced Therapy Medicinal Products (ATMPs) Market Segmentation
4.1 By Product Type
4.1.1 Cell Therapy
4.1.2 Gene Therapy
4.1.3 CAR-T Therapy
4.1.4 Tissue Engineered Product
4.2 By Disease Type
4.2.1 Alzheimer’s
4.2.2 Cystic Fibrosis
4.2.3 Muscular Dystrophies
4.2.4 Hemophilia
4.3 By Distribution Channel
4.3.1 Hospital Pharmacy
4.3.2 Drug Store
4.3.3 Retail Store
4.3.4 Online Pharmacy
5. Global Advanced Therapy Medicinal Products (ATMPs) Market Share
5.1 Market Analysis, Insights, and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
7. Key Company Profiles
7.1 Company 1
7.1.1 Overview
7.1.2 Financial Performance
7.1.3 Product & Services
7.1.4 Strategic initiatives
7.2 Company 2
7.2.1 Overview
7.2.2 Financial Performance
7.2.3 Product & Services
7.2.4 Strategic initiatives
7.3 Company 3
7.3.1 Overview
7.3.2 Financial Performance
7.3.3 Product & Services
7.3.4 Strategic initiatives
7.4 Company 4
7.4.1 Overview
7.4.2 Financial Performance
7.4.3 Product & Services
7.4.4 Strategic initiatives
7.5 Company 5
7.5.1 Overview
7.5.2 Financial Performance
7.5.3 Product & Services
7.5.4 Strategic initiatives
8. Healthcare Policies and Regulatory Landscape
8.1 Healthcare Policies in Global
8.2 Regulatory Framework in Global
8.3 Pricing & Reimbursement Scenario in Global Advanced Therapy Medicinal Products (ATMPs) Market
9. Factors Driving Future Growth
9.1 New Trends and Development Global Advanced Therapy Medicinal Products (ATMPs) Market
